Skip to main content
Log in

Hemogram and Myelogram in Progressing Non-Hodgkin's Lymphomas

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Parameters of hemogram and myelogram were studied in patients with aggressive and indolent non-Hodgkin's lymphomas: the relationships between the parameters recorded before treatment and during remission or progress 6 months after chemotherapy were studied by multifactorial analysis. The progress of indolent non-Hodgkin's lymphomas was associated with changes caused by tumor infiltration of the bone marrow; lymphocytosis in the myelogram or hemogram was associated with a relative decrease in the count of granulocytic hemopoietic stem cells. A sign associated with the absence of remission in aggressive non-Hodgkin's lymphomas was decreased level of hemoglobin and erythroid cells. Changes in myelogram attesting to anemia and suppressed erythropoiesis before chemotherapy are additional prognostic factors indicating obligatory intensification of chemotherapy for patients with aggressive non-Hodgkin's lymphomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. M. A. Volkova, Clinical Oncohematology [in Russian], Moscow (2001).

  2. A. I. Vorob'ev, Manual of Hematology [in Russian], Moscow (1985).

  3. M. L. Gershanovich and M. A. Akimov, Vopr. Onkol., 45, No.4, 438–440 (1999).

    PubMed  Google Scholar 

  4. N. P. Domnikova, V. V. Degtyareva, and L. M. Nepomnyashchikh, Byull. Eksp. Biol. Med., 138, No.12, 668–673 (2004).

    Google Scholar 

  5. A. Hagenbik and A. Novik, Diagnosis and Treatment of Lymphomas [in Russian] (2002), pp. 73–136.

  6. O. E. Yaguzhinskaya, I. E. Lazarev, E. A. Nikitin, et al., Ter. Arkhiv, No. 4, 45–51 (2001).

  7. J. O. Armitage, D. D. Weinburger, M. Hutchins, et al., J. Clin. Oncol., No. 4, 160–164 (1986).

  8. M. Cazzola, Y. Beguin, J. Kloczko, et al., Br. J. Haematol., 122,Suppl. 3, 386–393 (2003).

    Article  PubMed  Google Scholar 

  9. A. M. Gianni, M. Bregni, S. Siena, et al., N. Engl. J. Med., 336, 1290–1297 (1997).

    Article  PubMed  Google Scholar 

  10. R. T. Means and S. B. Krants, J. Clin. Invest., 91, 416–419 (1993).

    PubMed  Google Scholar 

  11. T. J. Morrow, S. Volpe, S. Gupta, et al., South Med. J., 95,Suppl. 8, 889–896 (2002).

    PubMed  Google Scholar 

  12. I. Moullet, G. Salles, N. Ketterer, et al., Ann. Oncol., 9, 1109–1115 (1998).

    Article  PubMed  Google Scholar 

  13. C. Nicolaidas, S. Dimou, and N. Pavlidis, Oncologist, No. 3, 189–197 (1998).

  14. M. A. Shipp, D. P. Harrington, J. R. Anderson, et al., N. Engl. J. Med., 329, 987–994 (1993).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. P. Domnikova.

Additional information

__________

Translated from Byulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 140, No. 7, pp. 95–99, July, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Domnikova, N.P., Degtyareva, V.V., Mukhin, O.V. et al. Hemogram and Myelogram in Progressing Non-Hodgkin's Lymphomas. Bull Exp Biol Med 140, 83–87 (2005). https://doi.org/10.1007/s10517-005-0418-8

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-005-0418-8

Key Words

Navigation